Previous Close | 0.1150 |
Open | 0.0300 |
Bid | 0.0500 x 0 |
Ask | 0.0950 x 0 |
Day's Range | 0.0300 - 0.0500 |
52 Week Range | 0.0300 - 0.1150 |
Volume | |
Avg. Volume | 0 |
Market Cap | 675,645 |
Beta (5Y Monthly) | 2.02 |
PE Ratio (TTM) | N/A |
EPS (TTM) | -0.0100 |
Earnings Date | N/A |
Forward Dividend & Yield | N/A (N/A) |
Ex-Dividend Date | N/A |
1y Target Est | N/A |
Venerable Ventures Ltd. (the "Company") (TSXV: VLV) announces further to its news release on February 20, 2024, the Company is on a 90 days' Notice to transfer to NEX board of the TSX Venture Exchange for not meeting Tier 2 Continued Listing Requirements ("Tier 2 CLR"). Trading in the common shares of the Company will resume effective at the opening on Tuesday, April 23, 2024 under the ticker symbol TSXV: VLV.
Venerable Ventures Ltd. (the "Company") (TSXV: VLV) announces that following discussions with Kapoose Creek Bio Corporation ("Kapoose") (formerly, Kapoose Creek Wellness Ltd.) it has agreed that it will not proceed with the proposed acquisition (the "Transaction") of Kapoose as previously announced on November 1, 2021.